K Number
K092233
Device Name
SURGIMESH XD
Manufacturer
Date Cleared
2010-06-25

(337 days)

Product Code
Regulation Number
878.3300
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The SURGIMESH®XD mesh is recommended for reinforcement of hernia defects. The hernia repair is for an inguinal hernia. The SURGIMESH®XD implant is indicated for use via an extraperitoneal approach either by open or laparoscopic surgery.
Device Description
The SURGIMESH®XD consists of non-absorbable synthetic mesh, made of polypropylene. The SURGIMESH®XD has a 3D shape to fit the inguinal anatomy. In addition, two translucent windows are incorporated into the SURGIMESH®XD implant to allow proper positioning of the implant. The two windows allow the surgeon to place the implant in the correct anatomical location using the Cooper's ligament and the spermatic cord as anatomical guides in repairing a hernia defect. SURGIMESH®XD mesh is supplied sterile.
More Information

Not Found

No
The device description and performance studies focus on the physical properties and biocompatibility of a surgical mesh, with no mention of AI or ML capabilities.

No
The device is a surgical mesh used to reinforce hernia defects, which is a physical repair rather than a therapeutic treatment in the sense of administering a drug or biological agent.

No

The device description indicates it is a surgical mesh made of polypropylene, designed for reinforcement of hernia defects. It does not mention any function related to diagnosing a condition or disease. Its purpose is for therapeutic intervention, not diagnostic evaluation.

No

The device description clearly states it is a non-absorbable synthetic mesh made of polypropylene with a 3D shape and translucent windows, indicating it is a physical implant, not software.

No, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In Vitro Diagnostic devices are used to examine specimens (like blood, urine, or tissue) taken from the human body to provide information for diagnosis, monitoring, or screening.
  • SURGIMESH®XD Function: The SURGIMESH®XD is a surgical implant used to physically reinforce hernia defects. It is placed directly into the body during surgery.
  • Lack of Specimen Analysis: The description of the SURGIMESH®XD does not involve any analysis of biological specimens outside of the body. Its function is purely mechanical and structural within the body.

The information provided clearly describes a surgical mesh for hernia repair, which is a type of implantable medical device, not an IVD.

N/A

Intended Use / Indications for Use

The SURGIMESH®XD mesh is recommended for reinforcement of hernia defects. The hernia repair is for an inguinal hernia. The SURGIMESH®XD implant is indicated for use via an extraperitoneal approach either by open or laparoscopic surgery.

Product codes

FTL

Device Description

The SURGIMESH®XD consists of non-absorbable synthetic mesh, made of polypropylene. The SURGIMESH®XD has a 3D shape to fit the inguinal anatomy. In addition, two translucent windows are incorporated into the SURGIMESH®XD implant to allow proper positioning of the implant. The two windows allow the surgeon to place the implant in the correct anatomical location using the Cooper's ligament and the spermatic cord as anatomical guides in repairing a hernia defect. SURGIMESH®XD mesh is supplied sterile.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

inguinal anatomy

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Preclinical testing was conducted. Biocompatibility, product structure, and final product specifications were all tested. In all instances, the SURGIMESH®XD functioned as intended and the results observed were as expected. Specifically, the company conducted the following performance testing:

  • Biocompatibility testing in accordance with ISO 10993-1 standards . were conducted and results demonstrated that the device is biocompatible per these standards;
  • Sterilization validation testing in accordance with ISO 10993-7, ISO . I 137-1, ISO 14937, and USP 28 and results demonstrated that the device is sterile per these standards;
  • . Product packaging testing in accordance with ISO 11607 and results demonstrated that the device packaging has the appropriate sealing characteristics:
  • . The device structure and product characterization testing was performed in accordance with ISO 5084, ISO 3801, ISO 9073-3, ISO 9073-4, ISO 9073-7, ISO 13934-1 and ISO 13938-1 and results demonstrated the SURGIMESH®XD specifications are substantially similar to the identified predicate device specifications. Testing was also perform in accordance with FDA's Guidance Document entitled. Guidance for the Preparation of a Premarket Notification Application for a Surgical Mesh (March 2, 1999).

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K061445, K081010, K020007

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 878.3300 Surgical mesh.

(a)
Identification. Surgical mesh is a metallic or polymeric screen intended to be implanted to reinforce soft tissue or bone where weakness exists. Examples of surgical mesh are metallic and polymeric mesh for hernia repair, and acetabular and cement restrictor mesh used during orthopedic surgery.(b)
Classification. Class II.

0

ASPIDE Médical

PREMARKET NOTIFICATION 510(k) SURGICAL MESH: SURGIMESH®XD

510(k) Summary

SURGIMESH®XD

JUN 2 5 2010

Submitter's Name, Address, Telephone Number, Contact Person and Date Prepared

ASPIDE MEDICAL 246 allée Lavoisier 42350 LA TALAUDIERE (FRANCE) Tel: +33 4 77 53 16 59 Fax: +33 4 77 53 01 97

Contact Person: Mr. William Wiecek

Date Prepared: June 24, 2010

Name of Device and Name/Address of Sponsor

SURGIMESH®XD

ASPIDE MEDICAL 246 allée Lavoisier 42350 LA TALAUDIERE (FRANCE)

Common or Usual Name

Polymeric Surgical Mesh

Classification Name

Surgical Mesh

Predicate Devices

(1) ASPIDE MEDICAL's SURGIMESH WN (K061445);

  • (2) BARD's 3D MAX (K081010); and
  • (3) PROMEDON's SAFYRE SLING (K020007),

Intended Use / Indications for Use

The SURGIMESH®XD mesh is recommended for reinforcement of hernia defects. The hernia repair is for an inguinal hernia. The SURGIMESH®XD implant is indicated for use via an extraperitoneal approach either by open or laparoscopic surgery,

Technological Characteristics

The SURGIMESH®XD consists of non-absorbable synthetic mesh, made of polypropylene. The SURGIMESH®XD has a 3D shape to fit the inguinal anatomy.

1

Image /page/1/Picture/1 description: The image shows the logo for "ASPIDE Médical". The word "ASPIDE" is in a sans-serif font, with a line underneath it. Below that, the word "Médical" is in a cursive font. Above the word "ASPIDE" is a graphic of a series of dots that form a triangle.

PREMARKET NOTIFICATION 510(k) SURGICAL MESH: SURGIMESH®XD

In addition, two translucent windows are incorporated into the SURGIMESH®XD implant to allow proper positioning of the implant. The two windows allow the surgeon to place the implant in the correct anatomical location using the Cooper's ligament and the spermatic cord as anatomical guides in repairing a hernia defect.

SURGIMESH®XD mesh is supplied sterile.

Performance Data

Preclinical testing was conducted. Biocompatibility, product structure, and final product specifications were all tested. In all instances, the SURGIMESH®XD functioned as intended and the results observed were as expected. Specifically, the company conducted the following performance testing:

  • Biocompatibility testing in accordance with ISO 10993-1 standards . were conducted and results demonstrated that the device is biocompatible per these standards;
  • Sterilization validation testing in accordance with ISO 10993-7, ISO . I 137-1, ISO 14937, and USP 28 and results demonstrated that the device is sterile per these standards;
  • . Product packaging testing in accordance with ISO 11607 and results demonstrated that the device packaging has the appropriate sealing characteristics:
  • . The device structure and product characterization testing was performed in accordance with ISO 5084, ISO 3801, ISO 9073-3, ISO 9073-4, ISO 9073-7, ISO 13934-1 and ISO 13938-1 and results demonstrated the SURGIMESH®XD specifications are substantially similar to the identified predicate device specifications. Testing was also perform in accordance with FDA's Guidance Document entitled. Guidance for the Preparation of a Premarket Notification Application for a Surgical Mesh (March 2, 1999).

Substantial Equivalence

The SURGIMESH®XD is substantially equivalent to: (1) ASPIDE MEDICAL's SURGIMESH WN (K061445); (2) BARD's 3D MAX (K081010); and (3) PROMEDON's SAFYRE SLING (K020007).

  • The SURGIMESH®XD has the same intended uses and similar indications, technological characteristics, and principles of operation as its predicate devices. The minor technological differences between the SURGIMESH®XD and its predicate devices raise no new issues of safety or effectiveness. The SURGIMESH®XD mesh's mechanical and material characteristics are substantially equivalent to its predicate devices. Thus, the SURGIMESH®XD is substantially equivalent.

2

Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three stripes representing the department's mission. The eagle is enclosed in a circle with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002

JUN 2 5 2010

Aspide Medical % Hogan & Hartson, LLP Mr. Howard M. Holstein Columbia Square 555 Thirteenth Street Northwest . Washington, District of Columbia 20004-1109

Re: K092233

Trade/Device Name: SURGIMESH®XD Regulation Number: 21 CFR 878.3300 Regulation Name: Surgical mesh Regulatory Class: II Product Code: FTL Dated: June 14, 2010 Received: June 14, 2010

Dear Mr. Holstein:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Iisting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must

3

Page 2 - Mr. Howard M. Holstein

comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm1118001.html for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFF) Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll fre number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm

Sincerely yours.

Sincerely yours,

For Peter D

Mark N. Melkerson

DEP Dir

Director Division of Surgical, Orthopedic · and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure .

4

Indications for Use Statement

510(k) Number (if known):

Device Name: SURGIMESH®XD

Indications for Use:

The SURGIMESH®XD mesh is recommended for reinforcement of hemia defects. The hernia repair is for an inguinal hernia. The SURGIMESH®XD implant is indicated for use via an extraperitoneal approach either by open or laparoscopic surgery.

...
... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..

Prescription Use X (Part 21 C.F.R. 801 Subpart D) AND/OR

Over-The-Counter Use (21 C.F.R. 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE -- CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

David Kramerfullxiy
(Division Sign-Off)

Division of Surgical, Orthopedic, and Restorative Devices

Page 1 of 1

510(k) Number K092233